Randomized trial · people

Ecnoglutide: HbA1c fell up to 2.43% at 24 weeks in EECOH-1

Checked against the paper Randomized trialPublished by PepVault

The takeaway

This phase 3 trial shows weekly ecnoglutide alone lowered HbA1c more than placebo over 24 weeks in adults with type 2 diabetes, with a larger drop in the 1.2 mg arm.

Kind
Randomized trial
Studied in
People
Number studied
211
Published
2026
Journal
Nat Commun

What they tested

The team tested whether once-weekly ecnoglutide, used on its own, lowers blood sugar better than placebo in adults with type 2 diabetes.

How the study was done

A randomized, double-blind, placebo-controlled phase 3 trial in 211 adults with type 2 diabetes at 32 centers in China, whose blood sugar was still too high on diet and exercise or one diabetes pill. They got a weekly shot of ecnoglutide 0.6 mg or 1.2 mg, or a matching placebo (a dummy shot), for 24 weeks.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking ecnoglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

After 24 weeks, HbA1c (an average of blood sugar over about 3 months) dropped 1.96% in the 0.6 mg arm and 2.43% in the 1.2 mg arm. The placebo group saw a drop of 0.87%. Compared with placebo, the 0.6 mg arm lowered HbA1c by an extra 1.09% (p = 0.0003) and the 1.2 mg arm by an extra 1.56% (p < 0.0001).

What it doesn’t show

The trial lasted 24 weeks and enrolled only people in China. It compared ecnoglutide with placebo, not with other diabetes or GLP-1 medicines.

The paper

Zhu et al. Efficacy and safety of cAMP signalling-biased GLP-1 analogue ecnoglutide monotherapy versus placebo in patients with type 2 diabetes (EECOH-1): a multi-centre, randomised, double-blind, placebo-controlled, phase 3 trial. Nat Commun. 2026.

The compound

More studies on Ecnoglutide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking ecnoglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo